• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX RX OXYGENATOR OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX RX OXYGENATOR OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX*RX25RW
Device Problem Device Damaged Prior to Use (2284)
Patient Problem No Patient Involvement (2645)
Event Date 09/28/2017
Event Type  malfunction  
Manufacturer Narrative
This report is being submitted as follow up no. To correct the veribage. It was stated in the simulation testing in the initial report in the section that: simulation testing was conducted based on the state of the damage observed on the actual device, a hypothesis that the actual device may have been exposed to shock force during transportation or storage was established. The reproductive tests were conducted as follows. A factory retained product sample of the involved product code was dropped from five (5) meters high and subsequently was subjected to a leak test by circulating colored saline solution in it. No leak occurred. The lot number of the actual device indicates the actual device experienced a winter. A factory retained product sample of the involved product code was cooled down beforehand. The sample was then dropped from five (5) meters high and subsequently was subjected to a leak test by circulating colored saline solution in it. It leaked. The state of leak similar to the actual device was duplicated. It should have stated: simulation testing was conducted based on the state of the damage observed on the actual device, a hypothesis that the actual device may have been exposed to shock force during transportation or storage was established. The reproductive tests were conducted as follows. A factory retained product sample of the involved product code was dropped from 1. 5 meters high and subsequently was subjected to a leak test by circulating colored saline solution in it. No leak occurred. The lot number of the actual device indicates the actual device experienced a winter. A factory retained product sample of the involved product code was cooled down beforehand. The sample was then dropped from 1. 5 meters high and subsequently was subjected to a leak test by circulating colored saline solution in it. It leaked. The state of leak similar to the actual device was duplicated.
 
Manufacturer Narrative
The actual device has been returned to the manufacturing facility for evaluation. Visual inspection found the finding: the oxygenator module had come off the reservoir and the reservoir had been deformed on the part to be fitted to the oxygenator module. No other anomalies were visible with the naked eye. Colored saline solution was circulated in the blood pathway of the oxygenator module. It leaked out of both lateral sides (the gas-in and gas-out sides). While the colored saline solution was being circulated in the oxygenator module, the fiber winding was observed under magnification for the location of the leak. It was revealed a leak was occurring in the inside of the fiber located on the most perimeter of the fiber winding. X-ray ct evaluation of the leaking segment revealed the urethane filling had been cracked and the fiber embedded there also had been cracked. A movie showing the involved customer's complaint was also provided for review. The movie confirmed the customer's complaint, air bubbles were seen on the gas-out side of the device. Simulation testing was conducted based on the state of the damage observed on the actual device, a hypothesis that the actual device may have been exposed to shock force during transportation or storage was established. The reproductive tests were conducted as follows. A factory retained product sample of the involved product code was dropped from five (5) meters high and subsequently was subjected to a leak test by circulating colored saline solution in it. No leak occurred. The lot number of the actual device indicates the actual device experienced a winter. A factory retained product sample of the involved product code was cooled down beforehand. The sample was then dropped from five (5) meters high and subsequently was subjected to a leak test by circulating colored saline solution in it. It leaked. The state of leak similar to the actual device was duplicated. A review of the device history record and product release decision control sheet of the involved product code/lot number combination revealed no relevant findings. A search of the complaint file found no previous report of this nature with the involved product code/lot number combination. There is no evidence this event was related to a device defect or malfunction. While the exact cause of the reported event cannot be definitively determined based on the available information, it is likely the actual device was cooled down during transportation or storage in winter. In this state, it was exposed to some shock force, resulting in a break on the reservoir and the generation of a crack on the urethane filling. Subsequently, when the involved customer used the broken unit, it leaked. As a cause of the generation of the air bubbles the customer observed during priming, it is likely when gas was sent to the actual device the leaked priming solution turned into foam and came out of the gas-out side. The device labeling does address the potential for such an event in the instructions-for-use (ifu) with statements such as the following: do not use if package or device is damaged (e. G. Cracked) or any of the port caps are off. Do not use an oxygenator and reservoir that leaks. Replace it with another capiox rx25 oxygenator and reservoir. (b)(4).
 
Event Description
The user facility reported a detached reservoir in the capiox device prior to a procedure. Follow up communication with the user facility confirmed the following information: upon opening the oxygenator box the perfusionist found the oxygenator detached from the reservoir; the perfusionist attached the reservoir back the oxygenator to do priming; after one hour of priming prior to the case, the perfusionist found the oxygenator forming bubbles; and there was no patient involvement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameCAPIOX RX OXYGENATOR
Type of DeviceOXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA 418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA 418
Manufacturer Contact
terry callahan
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key7009347
MDR Text Key250033206
Report Number9681834-2017-00231
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeMY
PMA/PMN Number
K040210
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation
Type of Report Initial,Followup
Report Date 11/08/2017
1 Device was Involved in the Event
0 Patients were Involved in the Event:
Date FDA Received11/08/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator
Device Expiration Date01/31/2018
Device Catalogue NumberCX*RX25RW
Device Lot Number150223
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/19/2017
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Event Location No Information
Date Manufacturer Received11/08/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/23/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

-
-